MR编号 | SE/H/1213/001 |
---|
药品名称 | Bufomix Easyhaler |
---|
活性成分 | - budesonide 80.0 µg/inhalation
- formoterol fumarate 4.5 µg/inhalation
|
---|
剂型 | Inhalation powder |
---|
上市许可持有人 | Orion Corporation
Finland |
---|
参考成员国 - 产品名称 | Sweden (SE) |
---|
互认成员国 - 产品名称 | - Austria (AT)
- Belgium (BE)
Bufomix Easyhaler - Bulgaria (BG)
Bufomyx Easyhaler - Czechia (CZ)
Bufomix Easyhaler - Germany (DE)
Bufomix Easyhaler 80/ 4,5 µg, Pulver zur Inhalation - Cyprus (CY)
BUFOMIX EASYHALER INHALATION PWD - Denmark (DK)
- Estonia (EE)
BUFOMIX EASYHALER - Greece (GR)
BUFOMIX® EASYHALER - Spain (ES)
- Finland (FI)
- France (FR)
- Hungary (HU)
- Ireland (IE)
- Iceland (IS)
- Italy (IT)
- Lithuania (LT)
- Luxembourg (LU)
Bufomix Easyhaler 320 mcg / 9 mcg Poudre pour inhalation - Latvia (LV)
- Malta (MT)
Bufomix Easyhaler - Netherlands (NL)
- Norway (NO)
- Poland (PL)
- Portugal (PT)
- Romania (RO)
Bufomix Easyhaler 80 micrograme/ 4.5 micrograme pulbere de inhalat - Slovenia (SI)
- Slovakia (SK)
Bufomix Easyhaler - United Kingdom (GB)
|
---|
许可日期 | 2014/03/06 |
---|
最近更新日期 | 2015/09/03 |
---|
药物ATC编码 | - R03AK07 formoterol and budesonide
申请类型 | - TypeLevel1:Abridged
- TypeLevel2:Initial Application
- TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Withdrawn(注:已撤市) 撤市原因:1.The company decided to withdraw the application. At the time of withdrawal, the MS considered that the data provided did not allow to conclude on a positive benefit-risk balance as major objections were raised. |
---|
|
---|